PUBHEA

COVID Science: Symptoms linger two years for some;  inflammatory protein patterns may provide long COVID clues

COVID Science: Symptoms linger two years for some; inflammatory protein patterns may provide long COVID clues

A medical worker prepares a syringe with a dose of the Johnson & Johnson coronavirus disease (COVID-19) vaccine during a visit of US Vice President Kamala Harris to a vaccination center in Chinatown, in Chicago, Illinois, US, April 6, 2021. Picture taken April 6, 2021. REUTERS/Carlos Barria Register now for FREE unlimited access to Reuters.com …

COVID Science: Symptoms linger two years for some; inflammatory protein patterns may provide long COVID clues Read More »

As Beijing tightens COVID curbs, hard-hit Shanghai sees signs of life

As Beijing tightens COVID curbs, hard-hit Shanghai sees signs of life

Beijing COVID outbreak enters 10th day Shanghai reports 2nd day of zero cases outside quarantine areas Shanghai starts to loosen curbs for some areas BEIJING/SHANGHAI, May 1 (Reuters) – The Chinese capital Beijing tightened COVID restrictions on Sunday as it battled an outbreak, while Shanghai let more of its 25 million residents venture out for …

As Beijing tightens COVID curbs, hard-hit Shanghai sees signs of life Read More »

The case for testing Pfizer's Paxlovid for treating long COVID

The case for testing Pfizer’s Paxlovid for treating long COVID

Two long COVID patients recover after Paxlovid treatment Side effects, safety issues need to be studied CHICAGO, April 18 (Reuters) – Reports of two patients who found relief from long COVID after taking Pfizer Inc’s (PFE.N) antiviral Paxlovid, including a researcher who tested it on herself, provide intriguing evidence for clinical trials to help those …

The case for testing Pfizer’s Paxlovid for treating long COVID Read More »